Randomized controlled study on the clinical efficacy of Tiaozhi Tongmai granule in the treatment of atherosclerosis

Phase 1

• Conditions: Atherosclerosis

• Registration Number: ITMCTR2200005935
• Lead Sponsor: Fangshan Hospital Beijing University of Chinese Medicine

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 20 February 2023

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

? Conform to the diagnostic criteria of carotid atherosclerosis;

? Conform to the standard of TCM syndrome differentiation;

? Middle aged and elderly people aged 45-70 (including 45 and 70);

? If you are taking drugs to treat carotid atherosclerosis, you need to stop the drug for more than 4 weeks;

? Sign the informed consent form (see Annex 1) and volunteer to participate in the trial;

Exclusion Criteria

? combined serious primary diseases such as cardio cerebrovascular, liver, kidney and hematopoietic system;

(2) combined type 2 diabetes mellitus with poor glycemic control and glycosylated hemoglobin (HbA1c) is more than 8%.

(3)combined type I diabetes mellitus and severe endocrine diseases;

? Coagulation dysfunction, or have been using anticoagulant drugs, such as warfarin and heparin;

? Pregnant or lactating women;

? Patients with mental diseases;

? Patients with acute infectious diseases;

? Patients with malignant tumors.

Study & Design

• Study Type: Interventional study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Carotid ultrasound;

Secondary Outcome Measures

Name	Time	Method
symptom score table of TCM;blood lipid;Inflammatory index;SF-36;blood sugar;